Vimarsana
Biggest News Aggregation in the World

Page 20 - Clinical Modification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Modification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Modification Today - Breaking & Trending Today

Females with diabetes at increased risk for premenstrual syndrome: Study - Vimarsana News

Females with diabetes at increased risk for premenstrual syndrome: Study

Taiwan: In a study, published in the journal Life, the researchers noted an association between diabetes mellitus (DM) and premenstrual syndrome (PMS) in female patients. The authors suggest that in...

Atopic Dermatitis Patients Treated with Crisaborole - Vimarsana News

Atopic Dermatitis Patients Treated with Crisaborole

Describing baseline characteristics, history of atopic dermatitis therapies, and use of healthcare services of early crisaborole users in real-world settings.

Economic Burden of Lyme Disease in High-Incidence Areas - Vimarsana News

Economic Burden of Lyme Disease in High-Incidence Areas

An economic evaluation of the costs associated with Lyme disease underscores the importance of effective prevention measures.

Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study - Vimarsana News

Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study

In a retrospective study, Carlos King Ho Wong, Kristy Tsz Kwan Lau, and colleagues study adverse events reported following COVID-19 vaccination in Hong Kong.

Source: plos.org
Data suggests no increase in pediatric hepatitis, adenovirus above pre-pandemic levels - Vimarsana News

Data suggests no increase in pediatric hepatitis, adenovirus above pre-pandemic levels

Data reported in Morbidity and Mortality Weekly Report did not demonstrate an increase in pediatric hepatitis or adenovirus types 40/41 above pre-COVID-19 pandemic baseline levels.“Following identification of pediatric hepatitis cases of unknown etiology in the United States and the United Kingdom, CDC issued a request in April 2022 for U.S. providers to report additional cases,”

Source: healio.com